Φορτώνει......
Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis
Rationale: Chronic azithromycin is commonly used in cystic fibrosis based on short controlled clinical trials showing reductions in pulmonary exacerbations and improved FEV(1). Long-term effects are unknown. Objectives: Examine pulmonary outcomes among chronic azithromycin users compared with matche...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Am J Respir Crit Care Med |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
American Thoracic Society
2020
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7049934/ https://ncbi.nlm.nih.gov/pubmed/31661302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201906-1206OC |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|